Sigilon Therapeutics, Inc. carries a market capitalization of 56.22M, placing it among publicly traded companies globally.
| Market Cap | 56.22M |
| Enterprise Value | N/A |
Sigilon Therapeutics, Inc.'s stock has gained approximately 166.23223% over the past 52 weeks. The 50-day moving average sits at 14.79, while the 200-day moving average is 9.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | 166.23223% |
| 50-Day Moving Average | 14.79 |
| 200-Day Moving Average | 9.81 |
| Average Volume (20 Days) | N/A |
Sigilon Therapeutics, Inc.'s most recent stock split took place on May 23, 2023 with a 13:1 split ratio.
| Last Split Date | 5/23/2023 |
| Split Ratio | 13:1 |